AirSculpt refinances with $39M Blue Torch loan as revenue slides 8.7%
What's the deal? AirSculpt Technologies, the Tampa-based body contouring provider, closed a $39 million senior secured term loan from Blue Torch Finance on November 5, 2026. The deal, funded in full at closing, came with an undrawn $5 million revolving credit facility and a 2031 maturity.
Why now? The loan repaid and terminated AirSculpt's prior credit agreement with Silicon Valley Bank, which had been amended in August to push maturity only to November 2027. The refinancing extends the runway by four years and eases near-term pressure.
What's the catch? The debt is expensive. Borrowings carry interest of Term SOFR plus a margin of up to 7.75%, and the agreement requires minimum weekly liquidity of $7.5 million through September 2027 and a maximum leverage ratio starting at 4.50:1.00.
What could go wrong? Operating results are weakening. Third-quarter revenue fell 8.7% to $31.9 million, same-center case volume dropped 9.6%, and adjusted EBITDA shrank to $393,000 from $3 million a year earlier.
AirSculpt also cut its 2026 outlook, trimming revenue guidance to roughly $144 million to $146 million from $151 million to $157 million.
What's the endgame? Chief executive officer Yogi Jashnani called the refinancing "a key milestone" and pointed to expanding GLP-1-related procedures, which made up about 10% of cases in the quarter. The company said it remains confident in its ability to "deliver sustainable, profitable long-term growth."
The signal: This is a buy-time deal, not a growth bet. With demand for premium elective procedures softening and costly new covenants in place, AirSculpt's challenge is stabilising volume and earnings before the new maturity clock matters.
Read more: kalkinemedia.com
Image credit: Generated with Gemini
